Trial Profile
A Phase II Study of TAS-117 in Advanced Solid Tumors With PI3K/AKT Gene Aberration (Part of K-BASKET Trial; Korea-Biomarker-driven Multi-arm Drug-screening, Knowledge and Evidence-generating Targeted Trial)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 05 Nov 2021
Price :
$35
*
At a glance
- Drugs Pifusertib (Primary)
- Indications Advanced breast cancer; Colon cancer; Endometrial cancer; Gallbladder cancer; Gastric cancer; Non-small cell lung cancer; Ovarian cancer; Rectal cancer; Solid tumours
- Focus Therapeutic Use
- 10 Apr 2021 Results presented at the 112th Annual Meeting of the American Association for Cancer Research
- 15 Mar 2021 Results published in the Investigational New Drugs
- 30 Jun 2020 Status changed from recruiting to completed.